CANCER Do aspirin and other NSAIDs protect against colorectal cancer?

被引：6
|
作者：
Kraus, Sarah [1 ]
Arber, Nadir [1 ]
机构：
[1] Tel Aviv Univ, Integrated Canc Prevent Ctr, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2011年 / 8卷 / 03期
关键词：
LOW-DOSE ASPIRIN; PRIMARY PREVENTION; RANDOMIZED-TRIAL; CHEMOPREVENTION; ADENOMAS; RISK;
D O I：
10.1038/nrgastro.2010.217
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
A recent study by Din et al. has demonstrated that a low dose of aspirin (75 mg per day) can decrease the incidence of colorectal cancer (CrC) after only 5 years of treatment. the study also shows that use of an nsaID before diagnosis of CrC does not improve survival.
引用
收藏
页码：125 / 126
页数：2
相关论文
共 50 条
12345